FDA Approved: TALVEY — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

The FDA approved Janssen's supplemental application for TALVEY (talquetamab), authorizing an update to the product labeling related to its indication or usage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TALVEY (talquetamab)

Snippet

SUPPL AP for TALVEY (TALQUETAMAB)